| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients.
|
Ann Oncol
|
2002
|
3.91
|
|
2
|
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib.
|
Ann Oncol
|
2010
|
2.11
|
|
3
|
Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
|
J Clin Oncol
|
2003
|
1.82
|
|
4
|
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
|
J Clin Oncol
|
2003
|
1.75
|
|
5
|
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma.
|
Ann Oncol
|
2005
|
1.71
|
|
6
|
Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data.
|
Eur J Nucl Med
|
2001
|
1.71
|
|
7
|
Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.
|
J Clin Oncol
|
1998
|
1.68
|
|
8
|
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib.
|
Eur J Cancer
|
2009
|
1.62
|
|
9
|
Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease.
|
Scand J Gastroenterol
|
2004
|
1.60
|
|
10
|
The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation.
|
Br J Cancer
|
2008
|
1.41
|
|
11
|
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases.
|
Br J Cancer
|
2012
|
1.35
|
|
12
|
Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)
|
Br J Cancer
|
1994
|
1.30
|
|
13
|
EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer.
|
Br J Cancer
|
2003
|
1.25
|
|
14
|
Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG).
|
Eur J Cancer
|
2003
|
1.24
|
|
15
|
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer.
|
J Clin Oncol
|
1999
|
1.17
|
|
16
|
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
|
J Clin Oncol
|
2002
|
1.11
|
|
17
|
Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.
|
Br J Cancer
|
2013
|
1.06
|
|
18
|
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin.
|
Br J Cancer
|
2012
|
1.06
|
|
19
|
Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatin.
|
Ann Oncol
|
2001
|
1.06
|
|
20
|
MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.
|
Br J Cancer
|
2013
|
0.98
|
|
21
|
Patient adherence to oral anticancer drugs: an emerging issue in modern oncology.
|
Acta Clin Belg
|
2011
|
0.95
|
|
22
|
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.
|
Ann Oncol
|
1996
|
0.92
|
|
23
|
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.
|
Ann Oncol
|
2012
|
0.90
|
|
24
|
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
|
Semin Oncol
|
1998
|
0.90
|
|
25
|
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
|
J Clin Oncol
|
1998
|
0.90
|
|
26
|
Phase II study of E7070 in patients with metastatic melanoma.
|
Ann Oncol
|
2005
|
0.90
|
|
27
|
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).
|
Ann Oncol
|
2013
|
0.88
|
|
28
|
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group.
|
Eur J Cancer
|
2003
|
0.87
|
|
29
|
Clinical implications of mutational analysis in gastrointestinal stromal tumours.
|
Br J Cancer
|
2008
|
0.87
|
|
30
|
Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer.
|
Ann Oncol
|
2001
|
0.86
|
|
31
|
Ecteinascidin-743: evidence of activity in advanced, pretreated soft tissue and bone sarcoma patients.
|
Sarcoma
|
2006
|
0.86
|
|
32
|
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer.
|
Br J Cancer
|
2002
|
0.85
|
|
33
|
Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.
|
B-ENT
|
2011
|
0.84
|
|
34
|
Topotecan in colorectal cancer: a phase II study of the EORTC early clinical trials group.
|
Ann Oncol
|
1995
|
0.83
|
|
35
|
Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours.
|
Eur J Cancer
|
2011
|
0.82
|
|
36
|
Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group.
|
Br J Cancer
|
1996
|
0.81
|
|
37
|
Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
|
Ann Oncol
|
1995
|
0.81
|
|
38
|
Bilateral testicular tumours: prevalence and clinical implications.
|
Eur J Cancer
|
1993
|
0.80
|
|
39
|
Adjuvant therapy for colon adenocarcinoma: current status of clinical investigation.
|
Ann Oncol
|
1994
|
0.80
|
|
40
|
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support.
|
Eur J Cancer
|
2003
|
0.80
|
|
41
|
Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report.
|
Transpl Infect Dis
|
2015
|
0.79
|
|
42
|
Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumors.
|
Invest New Drugs
|
2012
|
0.79
|
|
43
|
Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology.
|
Eur J Cancer
|
2012
|
0.79
|
|
44
|
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group.
|
Eur J Cancer
|
2007
|
0.78
|
|
45
|
Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.
|
Ann Oncol
|
1992
|
0.77
|
|
46
|
Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease.
|
Blood Coagul Fibrinolysis
|
2001
|
0.77
|
|
47
|
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer.
|
Cancer Chemother Pharmacol
|
2007
|
0.77
|
|
48
|
Plateletpheresis does not lead to a lasting increase in serum thrombopoiesis growth factor levels.
|
Transfusion
|
1999
|
0.76
|
|
49
|
UFT and oral calcium folinate as first-line chemotherapy for metastatic gastric cancer.
|
Oncology (Williston Park)
|
1999
|
0.76
|
|
50
|
Rituximab-induced fatal interstitial pneumonitis: case report.
|
Leuk Lymphoma
|
2010
|
0.76
|
|
51
|
[Germ-cell tumors of the testis. The epidemiological and etiological aspects].
|
Dtsch Med Wochenschr
|
1992
|
0.75
|
|
52
|
Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors.
|
Br J Cancer
|
2010
|
0.75
|
|
53
|
Docetaxel and cisplatin in head and neck cancer.
|
Ann Oncol
|
2000
|
0.75
|
|
54
|
The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.
|
J Infus Chemother
|
1996
|
0.75
|
|
55
|
A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults.
|
Cancer Chemother Pharmacol
|
1993
|
0.75
|
|
56
|
Endogenous serum levels of thrombopoietic cytokines in healthy whole-blood and platelet donors: implications for plateletpheresis.
|
Br J Haematol
|
1999
|
0.75
|
|
57
|
Familial occurrence of Leydig cell tumors: a report of a case in a father and his adult son.
|
J Urol
|
1993
|
0.75
|
|
58
|
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate in patients with advanced colorectal cancer. Results of a phase II study.
|
Eur J Cancer
|
1997
|
0.75
|
|
59
|
Sensitive and specific quantification of the anticancer agent ZD1839 (Gefitinib) in plasma by on-column focusing capillary liquid chromatography-tandem mass spectrometry.
|
J Chromatogr A
|
2005
|
0.75
|
|
60
|
[10 years transplantation of bone marrow and hematopoietic stem cells in adults at the Hannover Medical School].
|
Med Klin (Munich)
|
1996
|
0.75
|
|
61
|
A case series of embryonal rhabdomyosarcoma of the head and neck in adults.
|
Acta Clin Belg
|
2011
|
0.75
|
|
62
|
Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced colorectal cancer: preliminary results of a phase I/II trial.
|
Semin Oncol
|
1992
|
0.75
|
|
63
|
[Interesting case no. 9. Esthesioneuroblastoma (olfactory neuroblastoma)].
|
Laryngorhinootologie
|
1998
|
0.75
|